Font : A-A+

Drug information on Quinidine (Quinidine) from GlaxoSmithKline Pharmaceuticals Ltd

Quinidine   Tablet   GlaxoSmithKline Pharmaceuticals Ltd Generic : Quinidine	56.30 200mg 10 Tablets

Update the Drug Info

Malaria

Vector-Borne Diseases

•   Most Common : Diarrhea, nausea, vomiting and heartburn.

•   Central Nervous System : Lightheadedness, fatigue, weakness, nervousness and incoordination.

•   Heart : Palpitations.

•   Eye and ENT : Hearing loss, deafness, blurred vision, double vision, sensitivity to light, headache and confusion.

Adult: PO- Arrhythmia- As sulfate: 200-300 mg 3-4 times/day.
Malaria As sulfate: 300-600 mg 3-4 times/day for 5-7 days.

It comes as a tablet and capsule to take by mouth, with food.

Contraindicated in patients with myasthenia gravis, severe uncontrolled, abnormal heart rhythms and hypersensitivity.

• Caution should be exercised in patients with history of liver or kidney disease, heart failure, heart block, QT prolongation, low blood pressure, high/low blood calcium levels; decreased blood platelets; digitalis intoxication, any allergy, who are taking other medications, during pregnancy and breastfeeding.

• It may cause dizziness or blurred vision, do not drive a car or operate machinery while taking this medication.

• Avoid exposure to sunlight.

Avoid excess dosage.

Store it at room temperature and away from light.